Pulmoton inhaler (Budesonide + Formoterol fumarate dihydrate)

Pulmoton is a pharmaceutical product used for the treatment of asthma and chronic obstructive pulmonary disease (COPD). It consists of a combination of Budesonide and Formoterol fumarate dihydrate, administered via inhalation.

The brand is owned and manufactured by ELPEN Pharmaceutical Co. Inc., a leading Greek pharmaceutical company founded in 1965. ELPEN remains one of the largest Greek pharmaceutical industries, specializing in the development and production of generic and original pharmaceutical products, particularly focusing on respiratory healthcare and inhalation technology. The product is manufactured in ELPEN's production facilities located in Pikermi, Greece.